Author

C. Tian

Observed name: Congjian Tian

Institutions: Tianjin Beichen Hospital, Hunan University of Medicine

Observed institutions: Precision Therapeutics (United States), Tianjin Beichen Hospital, Hunan University of Medicine

ORCID: 0009-0003-4148-1795

Observed ORCID: 0009-0003-4148-1795

OpenAlex ID: A5102006079

Coptis chinensis and Berberine Ameliorate Chronic Ulcerative Colitis: An Integrated Microbiome-Metabolomics Study

2023 · Rui Zhou, Yangyi Huang, et al. · The American Journal of Chinese Medicine · 31

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

2013 · T. Rutherford, J. Orr, et al. · Gynecologic Oncology · 5

Clinical outcomes of intra-arterial chemotherapy combined with iodine-125 seed brachytherapy in the treatment of malignant superior vena cava syndrome caused by small cell lung cancer

2023 · Y. Wang, F. Li, et al. · Cancer/Radiothérapie · 3

Racial and ethnic outcome differences in the top five women’s cancers: A harmonized Surveillance, Epidemiology, and End Results study for diagnoses from 2000-2014

2017 · Y. Huang, E.A. Dubil, et al. · Gynecologic Oncology

Evaluation of the performance of breast cancer cell line–derived multigene predictors of chemotherapy response in multiple clinical trials.

2011 · N. Song, S. D. Rice, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 39

H-index: 3

I10-index: 1